Home/ Deals/ Prestige Consumer Health / portfolio of over-the-counter brands (Breathe Right Nasal Strips, Children’s Dimetapp, Anbesol)
Verified Healthcare Carve-out 15 Jun 2026

Prestige Consumer Health acquires portfolio of over-the-counter brands (Breathe Right Nasal Strips, Children’s Dimetapp, Anbesol)
for $1.0bn

Prestige Consumer Health → portfolio of over-the-counter brands (Breathe Right Nasal Strips, Children’s Dimetapp, Anbesol) · Healthcare · Carve-out

Close date15 Jun 2026
Announced20 Mar 2026
Deal value$1.0bn
Quality score96%
Acquirer HQ🇺🇸
Target HQ🇺🇸
AI-generated analysis

Prestige Consumer Healthcare acquired Breathe Right® and other brands to expand into new categories and enhance its portfolio.

◆ Generated by Claude (Anthropic) · Not investment advice · Methodology →

Sources & verification

1
Sawaya Partners
sawayapartners.com
Press
2
inforcapital.com
inforcapital.com
Press
3
biotechreporter.news
biotechreporter.news
Press
4
The Globe and Mail
theglobeandmail.com
Press

Verification quality score: 96%

Source count
1.00
Field completeness
0.97
AI confidence
0.85
Date plausibility
1.00
Value plausibility
1.00
Entity quality
1.00
See an error? Submit a correction → · All corrections reviewed within 24 hours.
Key facts
SectorHealthcare
Deal typeCarve-out
Value$1.0bn
Close date15 Jun 2026
Announced20 Mar 2026
Quality score96%
Acquirer HQ🇺🇸
Target HQ🇺🇸
Advisors
Sell-side financial
Canaccord Genuity
Export this deal
Related deals